Skip to main content
Fig. 1 | Trials

Fig. 1

From: A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy

Fig. 1

Schema of the trial. *An interim safety analysis for the period from the start of study treatment to the time when six patients complete the first course of treatment will be performed The outcome survey will be performed for the period from the date of secondary registration of the final case to Day 548

Back to article page